Abstract 2102: Metastatic-initiating signature-enriched subpopulation identified from single-cell transcriptomic sequencing of multi-timepoint esophageal squamous cell carcinoma pulmonary metastatic mice model
Authors: Ching Ngar Wong, Yu Zhang, Beibei Ru, Kwong Yiu Lam, Hongyu Zhou, Xinyuan Guan
Journal: Cancer Research (2023)

Abstract Esophageal squamous cell carcinoma (ESCC) metastatic-initiating cells are heterogenous subpopulations that are hypothesized to promote distal metastasis. Pulmonary metastatic human-origin ESCC mice model was established in our laboratory, chronological flow cytometry collection of tumor cells isolated from metastatic mice lungs at different timepoints inoculated via intravenous injection was followed by 10X genomics multiplex single-cell transcriptomic sequencing (scRNA-seq). Bioinformatics analyses denoted a 7-signature panel previously introduced with preliminary data, follow-up validations of signature-enriched subpopulation in silico, in vitro, and in vivo were performed in this study. In silico bulk transcriptomic sequencing (RNA-seq) of single signature-enriched KYSE30 subpopulation followed by gene ontology (GO) enrichment analyses indicated significantly (FDR&amp;lt;0.05) enhanced biological processes involved in cell motility, cell migration and cell adhesion, compared to signature-low subpopulation. In vitro western blotting showed elevated mesenchymal markers expression, while diminished epithelial markers expression. In vitro real-time qPCR revealed single signature-enriched subpopulation has co-enrichment of other signature marker RNAs compared to control group. Further in vitro functional assays demonstrated signature-enriched subpopulation possesses strengthened spheroid formation ability (p&amp;lt;0.05) and soft agar colony formation ability (p&amp;lt;0.05) as compared to signature-low subpopulation. In addition to previous preliminary data on early survival ability in vivo, signature-enriched subpopulation was significantly more favorable in sustained cell survival and proliferation, and formation of larger size of metastatic lesions in mice lungs at 2 months post-intravenous injection as illustrated by flow cytometry (p&amp;lt;0.05) and immunohistochemistry (IHC) staining analyses (p&amp;lt;0.05) respectively as compared to signature-low subpopulation. To validate the protein expression of signature markers, 6-colour multiplex IHC staining was performed on KYSE30 cell line and metastatic mice lungs collected at different timepoints. Multiplex IHC staining exhibited that these signature markers were expressed in subpopulation of cells as well as expressed on inoculated tumor cells in metastatic mice lungs with timeline pattern. In summary, signature-enriched subpopulation manifested the metastatic-initiating properties in ESCC via various in silico, in vitro, and in vivo experimental analyses. Further multiplex staining in clinical tissue microarray would be performed and analyzed to examine feasibility of adopting these signature markers for facilitating clinical diagnosis and molecular targeting of metastatic ESCC. Citation Format: Ching Ngar Wong, Yu Zhang, Beibei Ru, Kwong Yiu Lam, Hongyu Zhou, Xinyuan Guan. Metastatic-initiating signature-enriched subpopulation identified from single-cell transcriptomic sequencing of multi-timepoint esophageal squamous cell carcinoma pulmonary metastatic mice model [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 2102.